![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huayi Pharmaceutical Co., Ltd. Yiwu Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Clarithromycin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-302 - Rev 00
This Chemical Type CEP, issued on March 04, 2013, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1651 associated with this CEP further emphasizes